Methyl 3,6-dibromoimidazo[1,2-a]pyrazine-8-carboxylate

Catalog No.: 
ACXAPY507
CAS No.: 
1420670-22-9
Molecular Formula: 
C8H5Br2N3O2
Molecular Weight: 
334.95
Methyl 3,6-dibromoimidazo[1,2-a]pyrazine-8-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$214.00InquiryInquiry
1g95%$652.00InquiryInquiry
5g95%$3195.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 3,6-dibromoimidazo[1,2-a]pyrazine-8-carboxylate
IUPAC Namemethyl 3,6-dibromoimidazo[1,2-a]pyrazine-8-carboxylate
MDL No.MFCD13195319
Molecular FormulaC8H5Br2N3O2
Molecular Weight334.95
SMILESO=C(C1=NC(Br)=CN2C1=NC=C2Br)OC
InChI KeyFIRWZPRXRGWXIC-UHFFFAOYSA-N
SynonymMethyl 3,6-dibromoimidazo[1,2-a]pyrazine-8-carboxylate;Imidazo[1,2-a]pyrazine-8-carboxylic acid, 3,6-dibromo-, methyl ester;3,6-Dibromo-imidazo[1,2-a]pyrazine-8-carboxylic acid methyl ester
CAS No.1420670-22-9

Synthetic Route by SureRoute

1. ACXAPY507 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAXFK857 route compound structure diagram
    ACAXFK85763744-24-1In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXAPY507 route product structure diagram
    ACXAPY5071420670-22-9
Inquiry

2. ACXAPY507 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXAPY507 route product structure diagram
    ACXAPY5071420670-22-9
Inquiry

3. ACXAPY507 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXAPY507 route product structure diagram
    ACXAPY5071420670-22-9
Inquiry

Comments (0)